Literature DB >> 19776758

Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidine.

M Wermke, C Thiede, A Kiani, G Ehninger, M Bornhäuser, U Platzbecker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19776758     DOI： 10.1038/leu.2009.204

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse.

Authors:  Katja Sockel; Martin Wermke; Jörgen Radke; Alexander Kiani; Markus Schaich; Martin Bornhäuser; Gerhard Ehninger; Christian Thiede; Uwe Platzbecker
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

Review 2.  Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.

Authors:  P Sportoletti; E Varasano; R Rossi; A Mupo; E Tiacci; G Vassiliou; M P Martelli; B Falini
Journal:  Leukemia       Date:  2014-09-02       Impact factor: 11.528

Review 3.  Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia.

Authors:  Justin Loke; Hrushikesh Vyas; Charles Craddock
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.